Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07131605

Effects of Bariatric Surgery on Cardiovascular Risk Profile in Relation to Inflammatory Parameters: Endothelial Phenotyping and Analysis of the Cross-talk Between Adipose Tissue and Endothelium

Led by Maria Cecilia Hospital · Updated on 2026-05-08

85

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research project aims to study how obesity affects the heart and metabolism, and how these effects change after significant weight loss following bariatric surgery. In particular, we want to look at how blood vessels and fat tissue function in people with obesity, to detect early signs of vascular problems and understand how fat tissue communicates with blood vessels. Our main idea is that obesity disrupts the normal function of blood vessels, partly due to substances released by fat tissue and changes in gut bacteria. We believe that 6 and 12 months after surgery - with proper weight loss - these problems will gradually improve. We expect to see better blood vessel function and lower levels of inflammation and fat-related substances in the blood, which could significantly reduce the overall risk of heart disease.

CONDITIONS

Official Title

Effects of Bariatric Surgery on Cardiovascular Risk Profile in Relation to Inflammatory Parameters: Endothelial Phenotyping and Analysis of the Cross-talk Between Adipose Tissue and Endothelium

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Obesity with Body Mass Index of 30 kg/m² or higher
  • Scheduled for bariatric surgery via mini-gastric bypass or sleeve gastrectomy
  • Able to give informed consent for personal data processing
  • Willing to attend follow-up visits and complete all study assessments
Not Eligible

You will not qualify if you...

  • Active systemic inflammatory diseases such as chronic inflammatory bowel disease or chronic rheumatologic diseases
  • Acute or chronic infections
  • Severe anemia or coagulation disorders
  • Moderate to severe chronic kidney disease
  • Active malignancies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maria Cecilia Hospital

Cotignola, Ravenna, Italy, 48033

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here